Chemical biologist Stefano Tiziani uses metabolomics to identify new combination cancer treatments and to predict which patients will respond best to chemotherapy.
There are now more cancer treatment options than ever before. However, almost all of them face the same major challenge: eventually, they stop working. There are several unique ways in which cancer cells evade death. Now, scientists are inventing new technologies to target these mechanisms and overcome resistance.
We’ve updated our Privacy Policy to make it clearer how we use your personal data. Please read our Cookie Policy to learn how we use cookies to provide you with a better experience.